GMDx Genomics is a genomic testing company using machine learning (ML) and patented algorithms to provide a comprehensive and individualized Innate Immune Fitness (IIF) profile.
GMDx can analyse a whole genome or whole exome from any laboratory source to determine the health of an individual’s immune fitness and enables a personalised cancer treatment plan.
The GMDx enabling platform utilises an industry-leading framework developed by stack partners Applied Precision Medicine that is built on the Oracle Autonomous Cloud. The platform is readily accessible GMDx partners globally. The Oracle partnership ensures compliance with all privacy and security requirements and the platform is designed for rapid scaling.
Our executives explain the incredible work that has been achieved by GMDx and our dedicated team.